B-type natriuretic peptide measurement in heart failure

Daniel M. Spevack, Arthur Schwartzbard

Research output: Contribution to journalReview article

9 Scopus citations

Abstract

Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.

Original languageEnglish (US)
Pages (from-to)489-494
Number of pages6
JournalClinical Cardiology
Volume27
Issue number9
DOIs
Publication statusPublished - Sep 2004

    Fingerprint

Keywords

  • B-type natriuretic peptide
  • Diagnosis
  • Heart failure
  • Natriuretic
  • Prognosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this